INTRODUCTION {#h0.0}
============

Genome-reduced pathogens typically display host-restricted behavior but retain the capacity to deploy complex mechanisms to effectively colonize mucosal sites critical for their dissemination to naive hosts. *Mycoplasma* species have evolved strategies to vary their surface topography to avoid detection and eradication by the host immune response ([@B1]). Mycoplasmas are the smallest self-replicating life forms with most genomes ranging in size from 500 to 1,300 kb. Gene families encoding proteins displayed on the surface with reiterated sequences in their promoter or coding regions are highly mutable due to slip strand mispairing and have been reported in a number of *Mycoplasma* species ([@B2]--[@B4]). Mutations in these reiterated regions generate phase (on/off) and size variants that contribute to surface diversity and immune evasion. *Mycoplasma hyopneumoniae* is unusual in this regard with analysis of four complete genome sequences failing to find evidence of reiterated sequences capable of inducing variable expression of most dominant surface proteins ([@B5]--[@B7]). Despite this, *M. hyopneumoniae* causes porcine enzootic pneumonia, a chronic geographically widespread respiratory disease that inflicts severe economic losses to pig production ([@B8], [@B9]).

Within the confines of commercial swine-rearing facilities, *M. hyopneumoniae* enters naive animals via the inhalation of mucorespiratory droplets expelled during bouts of coughing from *M. hyopneumoniae*-infected swine ([@B10]). Upon inhalation, *M. hyopneumoniae* must overcome the mucociliary escalator and traverse layers of heavily glycosylated mucins produced as decoys for bacterial adhesins that exploit surface glycoconjugates and extracellular matrix components during colonization. *M. hyopneumoniae* is highly adept at colonizing ciliated respiratory epithelia ([@B11], [@B12]) where it initially causes ciliostasis but eventually destroys cilia and induces epithelial cell death. Heparin effectively blocks the binding of *M. hyopneumoniae* to porcine cilial preparations ([@B13]), indicating that *M. hyopneumoniae* is reliant on the presentation of heparin-binding proteins on its cell surface. Proteoglycans with highly sulfated glycosaminoglycan (GAG) side chains are prominently displayed on the surface of ciliated epithelium lining the porcine respiratory tract ([@B14]). Enzootic pneumonia is a chronic disease, and adaptive immune responses must be evaded for *M. hyopneumoniae* to survive and proliferate within host tissues. Consequently, the ability to adhere tightly to respiratory cilia is a key strategy employed by pathogens to overcome the mucociliary escalator ([@B11], [@B13], [@B15], [@B16]).

Functional redundancy within key surface protein families is identified in multiple pathogens and may be a strategy to avoid immune responses and regulate both adhesion to host tissues and cellular invasion ([@B17], [@B18]). In *M. hyopneumoniae*, multifunctional adhesins belonging to the P97/P102 families include Mhp182 (P102), Mhp183 (P97), Mhp493 (P159), Mhp494 (P216), Mhp683 (P135), Mhp271, Mhp107, and Mhp108 (P116). These adhesins are prominently expressed during broth culture ([@B19]--[@B20; @B21; @B22; @B23; @B24; @B25; @B26; @B27; @B28][@B29]), and their expression *in vivo* is indicated by reverse transcription-PCR (RT-PCR) of *M. hyopneumoniae* mRNA recovered from the bronchoalveolar lavage (BAL) fluid of experimentally infected swine ([@B30]). P97/P102 paralog family members on the cell surface of *M. hyopneumoniae* are targets of endoproteolytic processing events that generate a substantial combinatorial repertoire of cleavage fragments. Fragments of P97, P216, P135, Mhp271, Mhp107, and Mhp108 have been shown to bind porcine cilia ([@B21]--[@B22; @B23; @B24; @B25][@B26]), underscoring their important role in colonizing the respiratory tracts of swine. Additionally, fragments derived from P97, P159, P216, P135, Mhp271, and Mhp107 are potent adhesins of heparin ([@B19], [@B21], [@B22], [@B24], [@B26], [@B31]). Interactions between microbial virulence factors and host GAGs underpin a plethora of pathogenic mechanisms including adhesion, invasion, and tissue tropism ([@B18]). These findings suggest that endoproteolytic fragments derived from P97/P102 paralog family members profoundly influence how *M. hyopneumoniae* interacts with its host.

Binding of plasminogen and fibronectin to the surface of *M. hyopneumoniae* is dose dependent and saturable ([@B24]--[@B26]), indicating that these two host proteins are also important targets during the infection process. Surface proteins P102 ([@B27]), P102 paralog Mhp108 (P116) ([@B25]), and P97 paralog Mhp107 ([@B26]) are strong plasminogen- and fibronectin-binding proteins, and the P97 paralog Mhp271 also binds fibronectin ([@B24]). Plasminogen is freely available at ciliated epithelial sites and in BAL fluid samples recovered from healthy and *M. hyopneumoniae*-infected swine. However, plasmin activity in BAL fluid samples increase significantly after challenge with *M. hyopneumoniae* ([@B27]). These observations indicate that *M. hyopneumoniae* engages the plasminogen activation system during colonization of the respiratory tract. Moreover, plasminogen exposed to recombinant P102 is more readily activated to plasmin in the presence of tissue-specific plasminogen activator (tPA). These data suggest that plasminogen-binding members of the P97/P102 paralog families can influence the tertiary structure of plasminogen, making it more susceptible to activation by plasminogen activators ([@B27]). Collectively, our studies show that P97/P102 paralog family members display discrete functional domains with multifunctional attributes and are key molecules in the pathogenic arsenal of *M. hyopneumoniae*.

Endoproteolytic processing is a well-known mechanism used by bacterial pathogens to convert immature preproteins into mature functioning virulence molecules; however, in the *M. hyopneumoniae* P97/P102 adhesin families, posttranslational cleavage is extensive and unorthodox. Most of the P97/P102 family members previously examined undergo at least one cleavage event and in some cases two or more cleavage events ([@B19]--[@B22], [@B28], [@B29]). The archetype cilium adhesin P97 itself undergoes extensive processing, creating many novel endoproteolytic fragments, but many of these fragments have not been experimentally characterized ([@B20]). Cleavage fragments reside on the surfaces of *M. hyopneumoniae* cells despite the lack of putative transmembrane domains ([@B19]--[@B27], [@B30]). Recently, the identification of an endoproteolytic cleavage motif with sequence S/T-X-F↓X-D/E has facilitated the prediction of cleavage sites among members of the P97/P102 families ([@B22]); however, the biological rationale for cleavage and the protease(s) responsible are yet to be determined.

The P146 adhesin-like-protein (Mhp684) is a paralog of the P97 cilium adhesin, and its corresponding gene is situated within a two-gene operon with the cilium- and heparin-binding protein P135 (Mhp683) ([@B6]). The gene itself is transcribed *in vivo* ([@B30]) and has garnered interest as a target for genotyping *M. hyopneumoniae*, due to its extensive variability in strains ([@B32]). A polyserine repeat (P146R3) is observed to vary considerably among the sequenced strains of *M. hyopneumoniae* ([@B5]--[@B7]). In this study, we have characterized binding functions of P146 and determined how it is endoproteolytically processed.

RESULTS {#h1}
=======

P146 is extensively processed on the surface of *M*. *hyopneumoniae.* {#h1.1}
---------------------------------------------------------------------

In pathogenic strain 232 of *M. hyopneumoniae*, the *p97* (*mhp183*) paralog *p146* (*mhp684*) encodes a 148.2-kDa protein with a theoretical pI of 8.79. Homologs of *p146* have been identified in the genome sequences of *M. hyopneumoniae* strains J (*mhj_0663*), 7448 (*mhp7448_0663*), and 168 (*mhp168_676*) ([@B5]--[@B7]). Additionally, *p146* homologs have been identified and sequenced in strains F7.2C and BQ14 and partially sequenced in strains PMS and 7422 ([@B32], [@B33]). The six full-length *p146* gene sequences share \>85% identity. The TMHMM algorithm identified a transmembrane domain (*P* = 0.999) spanning residues 7 to 29; however, SignalP 4.0 did not conclusively identify the presence of a putative signal peptide (D score of 0.44; signal peptide cutoff of D score of \>0.45).

Several members of the P97 and P102 families undergo extensive posttranslational cleavage ([@B19]--[@B22], [@B24], [@B25], [@B28], [@B29]). Expression of P146 by *M. hyopneumoniae* strain J in broth culture was established by using liquid chromatography with tandem mass spectrometry (LC-MS/MS) to identify tryptic peptides derived from proteins separated by SDS-PAGE ([Fig. 1](#fig1){ref-type="fig"}). Consistent with previously characterized P97/P102 family members and proteomic studies of *M. hyopneumoniae* ([@B28], [@B29]), we were unable to identify any peptides unique to P146 near its predicted mass of 148.2 kDa. Tryptic peptides spanning P146 mapped to three endoproteolytic fragments, indicating that P146 is cleaved twice. A protein that migrated with mass between 40 and 53 kDa (slice 8) mapped to the N-terminal region of P146 ([Fig. 1A](#fig1){ref-type="fig"}) (P50~P146~). Peptides matching the central region of the P146 sequence were identified in slices 8 (40 to 53 kDa) and 9 (39 to 42 kDa) ([Fig. 1B](#fig1){ref-type="fig"}) (P40~P146~), and peptides matching the C-terminal region were identified in slice 6 (70 to 90 kDa) ([Fig. 1C](#fig1){ref-type="fig"}) (P85~P146~). Recently, we proposed a cleavage motif with sequence S/T-X-F↓X-D/E that can be used to predict cleavage sites in the P97 and P102 paralog families ([@B22]). Two sequences that closely resemble this motif were identified within the cleavage regions defined by mass spectrometry. The first of these sequences, TYFAE, resides between amino acids 315 and 366 that separate matched peptides defining P50~P146~ and P40~P146~. However, we have been unable to experimentally confirm cleavage at the phenylalanine residue in TYFAE. The second motif, with sequence TEFQQ, resides between residues 630 and 675 that separate matched peptides that define P40~P146~ and P85~P146~. Analysis of spectra derived from P85~P146~ revealed a semitryptic peptide ^676^QQQDANSTNSSPTSPSPSPTSPSPASPSSSPSPTSPK^712^ that defines the N terminus of P85~P146~ (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material) and confirms the TEF↓QQ cleavage site.

![Mass spectrometry analysis of P146. *M. hyopneumoniae* strain J proteins were examined using the following two methods. In method 1, lysates were subjected to 1-D SDS-PAGE, the gels were sectioned into pieces representing 14 molecular mass ranges, and the proteins in each gel slice were examined using LC-MS/MS. In method 2, surface proteins were labeled by surface biotinylation and enriched by affinity chromatography of the cell lysate. Purified biotinylated proteins were separated by either 1-D SDS-PAGE or 2-D GE and identified by LC-MS/MS. Peptides identified by LC-MS/MS are shown in bold type and underlined. The numbers above or below the sequence refer to amino acid positions. (A to C) Peptides unique to three regions of the P146 sequence were identified in both experiments. Terminal sequences matching an *M. hyopneumoniae* cleavage motif defined previously are underlined but not bold. (A) Fragment P50~P146~ and peptides unique to the N-terminal region of P146. (B) Fragment P40~P146~ and peptides unique to the central region of P146. (C) Fragment P85~P146~ and peptides unique to the C-terminal region of P146. The N terminus of P85~P146~ was identified from a semitryptic peptide. (D to F) Additional proteins were identified by method 2 at masses significantly lower than those identified by method 1. Terminal sequences matching or almost matching an *M. hyopneumoniae* cleavage motif defined previously ([@B22]) are underlined but not bold. (D) Peptides unique to P50~P146~ were identified in a 1-D SDS-polyacrylamide gel slice containing proteins migrating at \~25 kDa. (E) Peptides unique to one-half of P50~P146~ identified in a 2-D GE protein spot migrating at 25 kDa and pI of \~5.5. (F) Peptides unique to P85~P146~ identified in 2-D GE protein spots migrating at 50 kDa and pI of \~5.0.](mbo0021212530001){#fig1}

To determine whether fragments of P146 reside on the surface of the bacterium, we biotinylated intact *M. hyopneumoniae* cells and enriched biotin-conjugated proteins from whole-cell extracts using a monomeric avidin column. Biotinylated surface proteins were then separated using both 1- and 2-D GE. Peptides unique to P50~P146~, P40~P146~, and P85~P146~ were identified from 2-D GE at molecular masses similar to those from previous 1-D SDS-PAGE with LC-MS/MS experiments ([Fig. 1A to C](#fig1){ref-type="fig"}). However, peptides unique to P146 fragments were also identified at masses significantly lower than those identified previously. Tryptic peptides mapping to P50~P146~ were identified from proteins with masses of \~25 kDa ([Fig. 1D](#fig1){ref-type="fig"}), indicating that a second, less efficient cleavage event may occur to separate the P50~P146~ fragment into two halves. Confirming this, peptides unique to the second half of P50~P146~ were identified from 2-D GE of biotinylated surface proteins at \~25 kDa ([Fig. 1E](#fig1){ref-type="fig"}). A peptide sequence, TKSFQT, similar to but not matching the S/T-X-F↓X-D/E cleavage motif, is found within the P50~P146~ fragment, indicating a possible cleavage site. Peptides unique to the P85~P146~ fragment were also identified from 2-D GE of biotinylated surface proteins in spots at \~50 kDa ([Fig. 1F](#fig1){ref-type="fig"}), which indicates further cleavage of these fragments.

While surface exposure of P146 endoproteolytic fragments was observed in biotinylation experiments, we also performed whole-cell digestion experiments with trypsin. Antisera generated against recombinant polyhistidine-tagged proteins F1~P146~, F2b~P146~, and F3~P146~, which recognize P50~P146~, P40~P146~, and P85~P146~, respectively ([Fig. 2](#fig2){ref-type="fig"}), were used to probe blots containing lysates of *M. hyopneumoniae* strain J cells exposed to different concentrations of trypsin for 15 min. The blots show that all P146 fragments are degraded by trypsin, confirming their surface location (see [Fig. S2A](#figS2){ref-type="supplementary-material"} in the supplemental material). In all immunoblots, trypsin digestion products are observed in concentrations as low as 0.5 µg ml^−1^, and major cleavage products are almost completely digested at a concentration of 50 µg ml^−1^. Immunoblots containing identical lysates probed with antisera raised against the ribosomal protein L7/L12 showed that this protein was still detected at a trypsin concentration of 300 µg ml^−1^. Consistent with previous experiments ([@B19], [@B21], [@B22], [@B25]--[@B27]), these data indicate that the cell membrane remained intact. We also performed mass spectrometry on peptides released from the surface of *M. hyopneumoniae* after trypsin digestion. Multiple peptides unique to all major cleavage fragments of P146 were identified by LC-MS/MS (see [Fig. S2B](#figS2){ref-type="supplementary-material"} in the supplemental material). Live/dead staining and flow cytometry of *M. hyopneumoniae* cells confirmed the absence of excessive cell lysis during trypsin and surface biotinylation experiments (data not shown).

![Cloning of *p146* and immunoblot analysis of its cleavage fragments. (A) *p146* (3954 bp encoding 1317 residues) was cloned from *M. hyopneumoniae* strain 232 homolog *mhp684* in three fragments (F1~P146/232~ to F3~P146/232~) closely matching native cleavage as observed by mass spectrometry. A hydrophobic transmembrane domain predicted by TMHMM (53 residues) was removed from the N terminus of F1~P146/232~. All in-frame TGA codons were mutated to TGG using overlap extension PCR. (B) Coomassie blue-stained SDS-PAGE of the three P146 recombinant proteins. The predicted mass (in kilodaltons) is shown above each gel lane. Recombinant protein F2~P146/232~ runs at a higher molecular mass than predicted. (C) Immunoblots of recombinant proteins (F1~P146/232~ to F3~P146/232~) and whole-cell lysates from *M. hyopneumoniae* strains 232 and J, probed with anti-F1~P146~ (αF1~P146~) and anti-F3~P146~ (αF3~P146~) sera. Sera labeled αF1~P146~ and αF3~P146~ were extracted from New Zealand White rabbits challenged with recombinants F1~P146/232~ and F3~P146/232~; anti-F2b~P146~ (αF2b~P146~) serum was generated in the same manner from a recombinant protein representing residues 586 to 690 of P146. Minor bands present in recombinant protein lanes (F1~P146/232~ to F3~P146/232~) may be either products of recombinant protein degradation or truncated proteins resulting from mRNA instability. (D) Immunoblots of recombinant proteins (F1~P146/232~ to F3~P146/232~) probed with porcine serum sourced from a high-health-status herd (blot 1) and sera from convalescent pigs (blots 2 and 3). (E) Immunoblots of recombinant proteins (F1~P146/232~ to F3~P146/232~) probed with sera obtained from a single pig prior to treatment (blot 1), after vaccination with the commercial bacterin vaccine Suvaxyn (blot 2), or 6 weeks after challenge with *M. hyopneumoniae* strain Hillcrest (blot 3).](mbo0021212530002){#fig2}

Antibodies from vaccinated, challenged, and convalescent pigs recognize P146. {#h1.2}
-----------------------------------------------------------------------------

To determine whether P146 sequences were recognized by the porcine humoral immune response, sera from pigs recovering from porcine enzootic pneumonia (convalescent-phase sera) were used to probe immunoblots of P146 recombinant proteins F1~P146~, F2~P146~, and F3~P146~. The results were compared with results for serum from a pig from a healthy herd (high-health-status sera) ([Fig. 2D](#fig2){ref-type="fig"}). Immunoblots probed with high-health-status sera (negative control) showed a strong reaction to F2~P146~ and weak reactions to F1~P146~ and F3~P146~. Immunoblots probed with sera from two separate convalescent pigs both showed increased reactions to all three recombinant proteins compared to the high-health-status sera. In addition to convalescent porcine sera, we also examined serum from a single pig vaccinated with the commercial bacterin vaccine Suvaxyn and serum from the same pig after subsequent challenge with a pathogenic strain of *M. hyopneumoniae* ([Fig. 2E](#fig2){ref-type="fig"}). Immunoblots probed with sera collected prior to vaccination again showed a strong reaction to F2~P146~ but no significant reactions to F1~P146~ and F3~P146~. All three recombinant proteins showed strong reactions when probed with sera collected after treatment with Suvaxyn and 6 weeks after challenge with virulent *M. hyopneumoniae* strain Hillcrest.

P146 is processed variably in *M*. *hyopneumoniae* field isolates. {#h1.3}
------------------------------------------------------------------

To determine whether the cleavage observed in P146 was consistent across multiple *M. hyopneumoniae* strains, cell lysates of laboratory strains and field isolates from varied geographical locations were analyzed by immunoblotting with anti-F1~P146~, anti-F2b~P146~, and anti-F3~P146~ sera. Processing of the P85~P146~, P50~P146~, and P40~P146~ fragments varied among strains ([Fig. 3A](#fig3){ref-type="fig"}). In strain J and field isolates 2-22421 and 95MP1509, strong bands at 40 kDa and 50 kDa were dominant when the blots were probed with anti-F1~P146~ and anti-F2b~P146~ sera, respectively. However, in strain 232 and field isolates OMZ407, C1735/2, and 00MP1301, dominant bands were also observed at \~80 and \~125 kDa with these antisera, indicating that cleavage of P146 may be less efficient in these strains. An \~80-kDa band that appears in immunoblots with anti-F1~P146~ and anti-F2b~P146~ sera suggests inefficient cleavage between P50~P146~ and P40~P146~, whereas a \~125-kDa band that appears in immunoblots with anti-F2b~P146~ and anti-F3~P146~ sera suggests inefficient cleavage between P40~P146~ and P85~P146~. To confirm this, we performed SDS-PAGE on a cell lysate of *M. hyopneumoniae* strain 232, sectioned the gel with molecular mass range from 75 to 125 kDa into 6 slices, digested them with trypsin, and examined the tryptic peptides eluted from each slice using LC-MS/MS ([Fig. 3B](#fig3){ref-type="fig"}). In gel slice 1 (\~110 to 125 kDa), peptides unique to both P40~P146~ and P85~P146~ were identified, indicating that an uncleaved fragment made of P40~P146~ and P85~P146~ was present ([Fig. 3C](#fig3){ref-type="fig"}). In gel slices 5 and 6 (\~75 to 85 kDa), peptides unique to P50~P146~, P40~P146~, and P85~P146~ were identified, indicating that an uncleaved fragment made of P50~P146~ and P40~P146~ was present migrating at a molecular mass similar to that of fragment P85~P146~ ([Fig. 3D](#fig3){ref-type="fig"}). In gel slice 4 (\~85 to 90 kDa), only peptides unique to fragment P85~P146~ were detected. Analysis of *M. hyopneumoniae* genome sequences reveals that both the TEFQQ and putative TYFAE motifs are present and unchanged in both strains J and 232 (data not shown).

![P146 is processed variably in *M. hyopneumoniae* laboratory strains and field isolates. (A) Immunoblots of whole-cell lysates of different *M. hyopneumoniae* strains and field isolates. The blots were separately probed with anti-F1~P146~ (αF1~P146~), anti-F2b~P146~ (αF2b~P146~), and anti-F3~P146~ (αF3~P146~) sera in order to assess the consistency of protein expression and processing. Cleavage fragments equivalent to P50~P146~, P40~P146~, and P85~P146~ are conserved across all isolates in this study, but some also show distinct bands at higher masses that correspond to fragments that would result from inefficient cleavage. (B) 1-D SDS-polyacrylamide gel (molecular mass region \~75 to 125 kDa) of an *M. hyopneumoniae* strain 232 cell lysate was sectioned into 6 slices, and each slice was examined using LC-MS/MS. (C) Slice 1 (\~110 to 125 kDa) was found to contain peptides unique to regions of P146 corresponding to P40~P146~ and P85~P146~ fragments and matched a band found at a similar mass in strain 232 immunoblots. (D) Slices 5 and 6 (\~75 to 85 kDa) were found to contain peptides unique to all major fragments of P146, suggesting that a cleavage event separated the protein into two separate \~80-kDa fragments.](mbo0021212530003){#fig3}

Molecular analysis of P146. {#h1.4}
---------------------------

P146 contains many striking sequence features, including three variable repeat regions, a KEKE repeat motif, and in strain J, a C terminus with the sequence SSSSAPAAAAAKAAK ([Fig. 4A](#fig4){ref-type="fig"}). Three repeat regions identified previously include a proline-glutamine repeat (P146R1) spanning residues 415 to 444 of the strain 232 sequence, a proline-serine repeat (P146R2) spanning residues 696 to 722, and a serine repeat (P146R3) spanning residues 1065 to 1085 ([@B33]). All three regions vary in length in strains ([@B33]). The serine repeat varies from 44 consecutive residues in strain 7448, 19 in strain J, and 21 residues in strain 232 ([@B6], [@B7]).

![*In silico* analysis of P146. (A) Sequence features of P146. The TMHMM algorithm predicts that P146 contains a transmembrane domain (*P* = 0.999). P146 contains three defined repeat regions: P146R1 (PQ), P146R2 (PS), and P146R3 (S). Multiple coiled-coil prediction algorithms identified two putative coiled-coils flanking the P146R3 repeat region in P85~P146~. The experimentally determined cleavage site (ATEFQQ) and predicted site (KTYFAE) are also shown. (B) PONDR VSL1 analysis of P146 232 homolog (Mhp684). The regions above the line at 0.5 denote regions predicted to be structurally disordered within P146. The thick black bars denote disordered regions spanning 40 or more amino acids. P146 is predicted to contain five regions of significant disorder, two corresponding with the experimental and predicted cleavage sites. The remaining disordered regions correspond to putative coiled-coil domains, the C-terminal region, and the P146R3 repeat region.](mbo0021212530004){#fig4}

P146 shares significant sequence identity with P97 family members of the *M. hyopneumoniae* genome, but this is essentially restricted to a region spanning \~400 amino acids from the N terminus. The remainder of the P146 protein is largely unique ([@B6]). Outside of the *M. hyopneumoniae* genome, BLASTP analysis determines that P146 shares the most similarity with hypothetical proteins of *Mycoplasma conjunctivae*: MCJ_004230, MCJ_004150, MCJ_005100, MCJ_003150, and the LppS adhesin; this is unsurprising considering previously reported similarity between adhesins of these *Mycoplasma* species ([@B34]). Analysis of P146 with coiled-coil prediction algorithms reveals two putative coiled-coil regions spanning residues 939 to 975 (coil 1) and 1210 to 1245 (coil 2) of the strain 232 sequence. The Paircoil2 ([@B35]) (coil 1 P score = 0.0078, coil 2 P score = 0.0155; coiled-coil predicted at a P score of \<0.025) and COILS algorithms ([@B36]) (coil 1 P score = 0.802, coil 2 P score = 1.000) both indicated that coil 1 and coil 2 regions form coiled-coil structures. The coil 2 region corresponds to a KEKE motif, and interestingly, a putative coiled-coil linked to a KEKE motif has been observed previously in the P146 operon partner Mhp683 ([@B22]).

Previously we have shown that dominant cleavage sites in P97 and P102 paralogs were located within regions of predicted protein disorder ([@B22]). Five regions of significant structural disorder were predicted in P146 using the VSL1 algorithm ([@B37]) spanning residues 324 to 508, 589 to 742, 917 to 1016, 1045 to 1098, and 1224 to 1317 ([Fig. 4B](#fig4){ref-type="fig"}). Cleavage motifs TYFAE (P50~P146~/P40~P146~) and TEFQQ (P40~P146~/P85~P146~) reside within two predicted disordered regions spanning amino acids 324 to 508 and 589 to 742. Interestingly, most of P40~P146~ is predicted to be disordered, and this fragment is clearly the most unstable compared to P50~P146~ and P85~P146~. This prediction suggests that P40~P146~ displays greater accessibility to endoproteolytic cleavage.

P146 fragments bind heparin. {#h1.5}
----------------------------

Members of the P97/P102 families have a propensity to bind sulfated GAGs ([@B19], [@B21], [@B22], [@B24], [@B26], [@B31]). Recombinant fragments F1~P146/232~ and F3~P146/232~ bound heparin in a dose-dependent and saturable manner with physiologically relevant affinity constants, as assessed in microtiter plate-based enzyme-linked immunosorbent assays (ELISAs) (see [Fig. S3A](#figS3){ref-type="supplementary-material"} in the supplemental material). F2~P146/232~ did not significantly bind heparin in microtiter plate assays (data not shown). F1~P146/232~ and F3~P146/232~ binding to heparin was largely specific, as the interactions were almost completely (F1~P146/232~) or mostly (F3~P146/232~) inhibited by the addition of a 50× excess unlabeled heparin. Affinity constants (*K~d~*) of 53 ± 10 nM and 520 ± 80 nM were calculated for F1~P146/232~ and F3~P146/232~, respectively. Preincubation of biotinylated heparin with unlabeled heparin or fucoidan inhibited binding of F1~P146/232~ and F3~P146/232~, while preincubation with porcine mucin or chondroitin sulfate B had limited or no significant effect (see [Fig. S3B](#figS3){ref-type="supplementary-material"} in the supplemental material).

F3~P146~ binds plasminogen. {#h1.6}
---------------------------

In *M. hyopneumoniae* and other bacterial pathogens, surface proteins possessing a C-terminal lysine residue have been correlated with the ability to bind the serine protease precursor plasminogen ([@B25]--[@B27], [@B38]). P146 homologs in strains J, F7.2C, and BQ14 possess a C-terminal lysine residue (-SSSSAPAAAAAKAA[K]{.ul}); however, in strains 232, 7448, and 168, the terminating residue is an arginine (-SSSSAPAAAAAAKAA[R]{.ul}). To determine whether this sequence variability influences interactions with plasminogen, we cloned F3~P146~ from both strains 232 and J and examined their binding to plasminogen using dot blotting and surface plasmon resonance (SPR). In dot blotting experiments, the J and 232 versions (F3~P146/J~ and F3~P146/232~) bound biotinylated plasminogen similarly (see [Fig. S4A](#figS4){ref-type="supplementary-material"} and S4B in the supplemental material). SPR experiments indicated that both also bound plasminogen in a dose-dependent manner with *K~d~* = 39 ± 3 nM and association rate (*k~a~*) = (4.6 ± 0.5) × 10^4^ M^−1^ s^−1^ for F3~P146/J~ and *K~d~* = 46 ± 6 nM and *k*~a~ = (1.7 ± 0.5) × 10^5^ M^−1^ s^−1^ for F3~P146/232~ (see [Fig. S4C](#figS4){ref-type="supplementary-material"} and S4D in the supplemental material). This suggests that whether the C-terminal basic residue is arginine or lysine has little effect on binding affinity; it does modestly affect the kinetics of interaction, with recognition of arginine being \~4-fold more efficient than lysine.

To examine this further, we cloned strain J and 232 versions of F3~P146~ without their respective C-terminal residues (F3~P146/JΔK~ and F3~P146/232ΔK~); these two proteins have near identical C-terminal sequences. Both displayed 5-fold-reduced affinity for plasminogen and as expected showed identical binding affinity and kinetics; *K~d~* = 210 ± 33 nM and *k~a~* = (1.3 ± 0.2) × 10^4^ M^−1^ s^−1^ for F3~P146/JΔK~ and *K~d~* of 220 ± 33 nM and *k~a~* = (1.3 ± 0.2) × 10^4^ M^−1^ s^−1^ for F3~P146/232ΔR~ (see [Fig. S4E](#figS4){ref-type="supplementary-material"} and S4F in the supplemental material). These data clearly quantify the significance of having a C-terminal basic residue (a 5-fold contribution to affinity) and whether it is a lysine or an arginine (an effect on binding kinetics).

P146 fragments bind porcine cilia. {#h1.7}
----------------------------------

A microtiter plate-based assay used previously to identify cilium-binding proteins showed that P146 recombinant proteins F1~P146/232~-F3~P146/232~ reproducibly bound cilia (see [Fig. S5](#figS5){ref-type="supplementary-material"} in the supplemental material). The recombinant protein F4~Mhp385~, derived from the C terminus of Mhp385 and previously observed to display low cilium-binding properties ([@B39]) did not bind porcine cilia and was included as a negative binding control in these studies. F2~P97~, a recombinant protein that carries the R1 cilium-binding domain of cilium adhesin P97, was used as a positive control and bound to porcine cilia as expected.

DISCUSSION {#h2}
==========

Members of the P97/P102 paralog families are secreted to the surface of *M. hyopneumoniae* where they play key roles in interactions with host cells, extracellular matrix components, and circulating host proteins ([@B19], [@B21]--[@B27], [@B30]). There are three overarching features that define members of these two protein families. The first feature is the presence of a single putative transmembrane domain at the N terminus that is not removed by signal peptidase 1 ([@B19], [@B20], [@B22]). Second, these molecules undergo endoproteolytic processing whereby N-terminal cleavage fragments presumably remain tethered to the cell membrane via the N-terminal transmembrane domain while central and C-terminal endoproteolytic fragments are released. Despite the absence of transmembrane domains distant from the N terminus, central and C-terminal cleavage fragments remain attached to the cell surface of *M. hyopneumoniae*, presumably by protein-protein interactions that are poorly understood. Third, P97 and P102 paralogs are multifunctional proteins that bind host cell-associated and circulatory molecules and present a variety of structural motifs with largely unknown functions ([@B19]--[@B22], [@B24]--[@B27]).

Here we show that P146, a paralog of P97, contains several structurally distinctive motifs including a polyserine repeat of unknown function and a serine/alanine-rich C-terminal motif \[SSSSAAAAAKAA(K/R)\] whose terminal K or R (strain-dependent) residue plays an important role in binding plasminogen (see [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material). We also identified two putative coiled-coil regions, one of which carries a KEKE motif, and a reiterated PQ motif, all of unknown function. Interestingly, these features are localized to the C-terminal 85 kDa of P146 (P85~P146~), while sequence similarity with P97 is restricted to the N-terminal 400 amino acids. Recombinant fragments spanning different regions of P146 identified at least three cilium-binding domains located in F1~P146/232~, F2~P146/232~, and F3~P146/232~, while GAG binding localized to F1~P146/232~ and F3~P146/232~. Residual high-affinity plasminogen binding retained after removal of C-terminal K/R residues in homologs from strains J and 232 indicate that additional plasminogen-binding sites are present. These data show that P146 is a multifunctional protein that binds porcine respiratory cilia, various GAGs, and plasminogen.

We have previously established that plasminogen is freely available in the bronchoalveolar regions of the porcine lung ([@B27]). *M. hyopneumoniae* displays surface receptors that bind plasminogen in a process that facilitates conversion to plasmin by mammalian plasminogen activators (e.g., tPA). Importantly, plasmin activity is significantly increased in the BAL fluid of pigs following infection with *M. hyopneumoniae* ([@B27]). Consequently, *M. hyopneumoniae* colonizing the ciliated epithelia is likely to sequester plasminogen on its cell surface and facilitate its conversion to plasmin. This process is likely to have ramifications for tissue invasion and systemic infection. To date, including P146, we have characterized four members of the P97 and P102 families as plasminogen-binding proteins, three of which contain C-terminal lysine residues ([@B25]--[@B27]). P146 is particularly interesting due to the variation of the C-terminal residue; the C-terminal residue was arginine in strains 232, 7448, and 168 and lysine in strains J, F7.2C, and BQ14. Lysine and arginine are both positively charged at physiological pH. We have shown that both strain J and 232 versions of F3~P146~ bind plasminogen using dot blotting and SPR. While the binding of plasminogen by proteins with C-terminal lysines is well established, binding of plasminogen by proteins with a C-terminal arginine residue is unusual. However, the *Streptococcus pyogenes* Prp protein has been shown to bind plasminogen via an internal arginine residue ([@B40]), and certain arginyl residues have been shown to bind human plasminogen kringle 4 ([@B41]). Thrombin-cleaved prourokinase has also been shown to bind human plasminogen via a C-terminal arginine present at the thrombin cleavage site ([@B42]).

F3~P146/232~ and F3~P146/J~ affinity for plasminogen is reduced 5-fold upon removal of the C-terminal Lys/Arg but is not eliminated, indicating the presence of other binding motifs within the F3~P146~ sequences. Both F3~P146/232~ and F3~P146/J~ are rich in internal lysine residues (66 and 68 lysines, respectively). Additionally, all known homologs of P146 possess a second lysine, 4 or 5 residues from the C terminus within a string of 7 or 8 alanine residues depending upon the strain. This near-C-terminal lysine or other internal lysines may be responsible for residual plasminogen binding observed in the F3~P146/JΔK~ and F3~P146/232ΔR~ mutants. Plasminogen binding by enolase from group A streptococci has previously been probed by mutation of C-terminal and internal lysines ([@B43]). Removal or replacement of C-terminal lysines with retention of internal lysines resulted in a significant reduction in the extent of binding ([@B43]). However, removal of some internal lysines also resulted in a significant reduction in the extent of binding, indicating that internal lysines also play an import role in plasminogen binding by enolase ([@B43]). Removal of internal lysines by site-directed mutagenesis and subsequent binding assays may also determine whether these residues have a role in F3~P146~ adherence to plasminogen.

LC-MS/MS of proteins resolved by 1- and 2-D gel electrophoresis identified endoproteolytic cleavage fragments representing P50~P146~, P40~P146~, and P85~P146~. Two sequences that conform to the S/T-X-F↓X-D/E cleavage motif described recently ([@B22]) were identified in regions spanning tryptic peptides that define these cleavage fragments. We confirmed the identity of one cleavage site by LC-MS/MS analysis of the semitryptic peptide ^676^QQQDANSTNSSPTSPSPSPTSPSPASPSSSPSPTSPK^712^ which defines the N terminus of the C-terminal cleavage fragment P85~P146~. The cleavage motif ^673^TEFQQ^677^ displays a S/T residue in the −3 position, and cleavage occurs at the Phe residue residing at position −1. Although no D/E is present in the +2 position, these features are in accord with cleavage sites in other members of the P97 and P102 paralogs ([@B22]). We were unable to experimentally confirm the putative cleavage site ^351^TYFAE^355^ predicted to generate P50~P146~ and P40~P146~.

Immunoblots of cell lysates of *M. hyopneumoniae* strains from different geographic locations probed separately with anti-F1~P146~ and anti-F3~P146~ sera showed that cleavage in strain 232 and field isolates OMZ407, C1735/2, and 00MP1301 is less efficient than in strain J and field isolates 2-22421 and 95MP1509. We have previously indicated that P97 (Mhp183) ([@B20]) and P159 (Mhp494) ([@B19]) undergo strain-specific processing events. However, the molecular identities of the strain-specific products were not identified. For the first time, we show here that strains of *M. hyopneumoniae* vary in their ability to efficiently cleave P146. We identified large endoproteolytic products comprising a C-terminal 120-kDa fragment (P85~P146~ plus P40~P146~), derived from an inefficient cleavage event at the ^673^TEFQQ^677^ site and an N-terminal P90~P146~ fragment (P50~P146~ plus P40~P146~), derived from inefficient processing at the putative ^351^TYFAE^355^ cleavage site ([Fig. 5](#fig5){ref-type="fig"}). P120~P146~ and P90~P146~ sequences were identified from high-molecular-mass regions of cell lysates of strain 232 by LC-MS/MS ([Fig. 1B to D](#fig1){ref-type="fig"}) and by probing cell lysates with anti-F1~P146~ and anti-F3~P146~ sera ([Fig. 3A](#fig3){ref-type="fig"}). We also identified minor endoproteolytic cleavage fragments with masses smaller than the dominant cleavage species P50~P146~, P40~P146~, and P85~P146~ by enriching biotinylated proteins with avidin chromatography ([Fig. 5](#fig5){ref-type="fig"}). LC-MS/MS of biotinylated proteins resolved by 2-D gel electrophoresis confirmed that P50~P146~ (predicted pI of 9.13) is cleaved to generate two fragments \~25 kDa in size. The C-terminal half of P50~P146~ is enriched in acidic amino acids (D or E residues). LC-MS/MS of a protein spot that migrated with a mass of \~25 kDa and pI of 5.5 confirmed that the protein represented the C terminus of P50~P146~. We have not determined the precise site of cleavage in P50~P146~. Minor fragments of P50~P146~ and P40~P146~ with different molecular masses were detected with anti-F1~P146~ and anti-F2b~P146~ sera, respectively ([Fig. 3](#fig3){ref-type="fig"}). This may indicate variation at the P50~P146~ C terminus and P40~P146~ N terminus caused by minor cleavage events ([Fig. 5](#fig5){ref-type="fig"}). LC-MS/MS identified a 50-kDa N-terminal fragment of P85~P146~ with a pI of \~5.0. It is interesting that the minor cleavage fragments identified by LC-MS/MS display predicted pI values that are considerably more acidic than those of P50~P146~ (pI = 9.13), P40~P146~ (9.33), and P85~P146~ (7.07), and of intact P146 (8.90). These data suggest that products of these minor cleavage events are not random breakdown products but represent domains enriched in acidic amino acids embedded within larger preproteins with strongly basic pIs. Furthermore, as noted for P159 (Mhp494) and P216 (Mhp493), regions enriched in acidic amino acid residues are a feature of members of the P97 and P102 paralog families ([@B19], [@B21]) and underscore their modular structure.

![Summary of P146 cleavage. Cleavage fragments can be split into three groups as shown. Strain-specific cleavage fragments are prevalent fragments in selected strains (e.g., strain 232). Major cleavage fragments P50~P146~, P40~P146~, and P85~P146~ are abundant in all strains. Minor cleavage fragments are present in small amounts and are detected only by enrichment of surface proteins.](mbo0021212530005){#fig5}

In total, we identified nine proteolytic cleavage fragments representing different regions of P146. These fragments are sensitive to digestion by trypsin, and many were recovered by avidin chromatography after the surfaces of *M. hyopneumoniae* cells were labeled with biotin. These data show that complex endoproteolytic processing events occur either on the surface of *M. hyopneumoniae* or prior to transport across the cell membrane. Processing is modulated by the efficiency of cleavage at dominant cleavage sites because different strains present different cleavage fragments on their cell surface. The mechanism by which *M. hyopneumoniae* regulates endoproteolytic cleavage remains unknown. Nonetheless, we have provided further evidence that cleavage often occurs at sites that conform to the S/T-X-F↓X-D/E cleavage motif described recently ([@B22]). P97 is also subject to extensive endoproteolysis, but so far the events that precipitate cleavage and the precise composition of many of the endoproteolytic fragments have not been experimentally determined ([@B20]). Endoproteolytic processing occurs with all members of the P97 and P102 paralog families, and in at least two cases (P97 and P146), processing is more extensive than originally envisaged. Endoproteolytic processing significantly increases surface protein diversity by altering the presentation of functional domains on the cell surface and may be a mechanism used to regulate adhesion to host tissues, potentiate host cell invasion, and avoid immune clearance.

MATERIALS AND METHODS {#h3}
=====================

Porcine sera and *Mycoplasma hyopneumoniae* strains and culture. {#h3.1}
----------------------------------------------------------------

Convalescent porcine sera were obtained from finisher pigs from a herd infected with *M. hyopneumoniae* in an area where *M. hyopneumoniae* is endemic (Joadja, Australia). High-health-status serum was obtained from a high-health-status herd and tested negative for *M. hyopneumoniae* infection using a commercial ELISA kit. Pretreatment (negative-control) serum was obtained from a 9-week-old pig that tested negative to *M. hyopneumoniae* by quantitative PCR (qPCR) ([@B44]). The pig was subsequently vaccinated at 9, 12, and 15 weeks with Suvaxyn. Postvaccination serum was collected 15 weeks after the third vaccination. The pig was challenged with *M. hyopneumoniae* strain Hillcrest at week 17 and postchallenge serum was collected at week 23. The sources and conditions used to culture and harvest *M. hyopneumoniae* strains J, 232, and Hillcrest and field isolates OMZ407, 00MP1301, 2-2241, C1735-2, and 95MP1509 are as previously described ([@B22], [@B24], [@B45]).

Proteomics and surface localization. {#h3.2}
------------------------------------

The materials and methods used for 1- and 2-D GE, immunoblotting, trypsin digestion, Zip-Tip cleanup, reduction, and alkylation have been previously described ([@B20], [@B24], [@B46]--[@B48]) with the following adjustments. For 2-D GE, first-dimension immobilized pH gradient (IPG) strips (ReadyStrip IPG strips, 110 mm long, pH 3 to 10; Bio-Rad) were used. The strips were rehydrated overnight with 300 µg of biotinylated surface protein in 210 µl of solubilization buffer \[7 M urea, 2 M thiourea, 1% (wt/vol) 3-(4-heptyl)phenyl-3-hydroxypropyl)dimethylammoniopropanesulfonate\] and overlaid with paraffin oil. *M. hyopneumoniae* proteins were reduced prior to 1-D SDS-PAGE for immunoblotting and reduced and alkylated with iodoacetamide prior to 1-D SDS-PAGE for LC-MS/MS. Gel slices prepared from 1-D SDS-PAGE for LC-MS/MS analysis were processed as previously described ([@B24]). LC-MS/MS analysis of 1- and 2-D GE excisions were done as previously described ([@B22], [@B49]), as were graded trypsin digestions of intact *M. hyopneumoniae* cells ([@B22]) and trypsin digestion experiments for mass spectrometry and biotinylation of the *M. hyopneumoniae* surface ([@B22]). Cell integrity for trypsin and biotinylation experiments was evaluated by flow cytometry with a BDTM LSR II (BD Biosciences, NJ) and YO-PRO-1 iodide dead cell dye (Invitrogen, CA) with data analyzed using BD FACSDiva software (BD Biosciences). Bioinformatic analysis of P146 used online resources: BLASTP ([@B50]), ProtParam ([@B51]), COILS ([@B36]), Paircoil2 ([@B35]), TMHMM ([@B52]), SignalP ([@B53]), and PONDR VSL1 ([@B37]).

Expression of recombinant proteins and creation of polyclonal antisera. {#h3.3}
-----------------------------------------------------------------------

Cloning of *p146* was performed by using three fragments of different lengths ([Fig. 2A](#fig2){ref-type="fig"}) and based on the *M. hyopneumoniae* strain 232 genome sequence ([@B6]); fragments were constructed to mimic the P146 cleavage pattern as determined by preliminary mass spectrometry experiments. The fragments were denoted F1~P146/232~, F2~P146/232~, and F3~P146/232~ and ranged from amino acids 53 to 372, 376 to 690, and 691 to 1317, respectively. F3~P146/J~ and F3~P146/JΔK~ were generated from *M. hyopneumoniae* strain J genome sequence ([@B7]). In-frame TGA codons were substituted by TGG and C-terminal residues (F3~P146/JΔK~ and F3~P146/232ΔR~) were removed by use of overlap extension PCR or site-directed mutagenesis using mutagenic primers (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material). The fragments were amplified by PCR from *M. hyopneumoniae* strain 232 chromosomal DNA using *Pfu* polymerase (Aglient Technologies, CA) and cloned into the pET100/GW/D-TOPO vector (Invitrogen) as described previously ([@B24]). Protein expression was performed using *Escherichia coli* BL21Star (DE3) as previously described ([@B27]) with the following alterations: protein expression was performed using either LB broth, Terrific broth, or 2× Terrific broth depending on the amount of proteolytic cleavage observed in preliminary experiments. Expression of recombinant proteins was initiated by incubating cells at 18°C for 30 min prior to the addition of isopropyl-β-d-thiogalactopyranoside (IPTG), followed by incubation at 18°C overnight. Recombinant proteins were purified natively by nickel affinity chromatography and dialyzed in phosphate-buffered saline (PBS) ([Fig. 2B](#fig2){ref-type="fig"}); their concentrations were estimated as described previously ([@B31]). Polyclonal antisera (anti-F1~P146/232~ and anti-F3~P146/232~ sera) to recombinant proteins F1~P146/232~ and F3~P146/232~ were prepared by immunization of New Zealand White rabbits as previously described ([@B54]). Polyclonal antiserum anti-F2b~P146~ was prepared similarly with a recombinant protein representing residues 586 to 690 of P146. For some immunoblots, purified anti-F1~P146/232~ antibodies were used to remove cross-reactions and were prepared as described previously ([@B55]). All antisera were tested for activity by immunoblotting with recombinant protein ([Fig. 2C](#fig2){ref-type="fig"}).

Binding assays. {#h3.4}
---------------

Heparin-binding, inhibition, and competitive immunoassays were performed in 96-well, flat-bottomed microtiter plates (Linbro/Titertek; ICN Biomedicals Inc., Aurora, OH) as described elsewhere ([@B31]). The binding of F1~P146/232~-F3~P146/232~ to porcine cilia was examined using a microtiter plate adherence assay developed for the identification of the cilium-binding protein P97 ([@B21]). SPR analyses were performed using a BIAcore T100 instrument (Biacore AB, Sweden), operated at 20°C. The preparation of analyte proteins, ligand immobilization, kinetics assays, porcine plasminogen purification, and biotinylation of plasminogen have been described previously ([@B25]). Plasminogen was immobilized as a ligand for SPR assays; binding of recombinant P146 proteins was measured with a concentration range of 0 to 200 nM. A blank immobilized flow cell was used as a reference cell. F3~P146~ association kinetics with plasminogen were analyzed as the sum of two exponentials for a heterogeneous surface as described previously ([@B24]). Plasminogen dot blots were performed ([@B24]) with 5 µg ml^−1^ biotinylated porcine plasminogen as described previously.

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

MS/MS spectrum of ^676^QQQDANSTNSSPTSPSPSPTSPSPASPSSSPSPTSPK^712^. Ions corresponding to fragmentation are denoted according to the nomenclature system of P. Roepstorff and J. Fohlman (Biomed. Mass Spectrom. **11**:601, 1984). Download [Figure S1, TIF file, 0.1 MB](/lookup/suppl/doi:10.1128/mBio.00282-11/-/DCSupplemental/mbo002121253sf01.tif).
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Figure S1, TIF file, 0.1 MB
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P146 fragments are present on the surface of *M. hyopneumoniae*. (A) Intact and washed *M. hyopneumoniae* (strain J) cells were exposed to different concentrations of trypsin (listed above the blots in micrograms per milliliter) for 15 min. Immunoblots were probed with anti-F1~P146~ (αF1~P146~), anti-F2~P146~ (αF2b~P146~), and anti-F3~P146~ (αF3~P146~) sera detecting the P50~P146~, P40~P146~, and P85~P146~ fragments, respectively. Identical lysates were subsequently probed with an intracellular control protein (ribosomal protein L7/L12) to confirm cell integrity. (B) Peptides unique to P146 (MHJ_0663) obtained by shaving washed, intact *M. hyopneumoniae* (strain J) with 50 µg ml^−1^ trypsin for 5 min. Underlined sequences indicate peptides identified by LC-MS/MS. Download [Figure S2, TIF file, 1.8 MB](/lookup/suppl/doi:10.1128/mBio.00282-11/-/DCSupplemental/mbo002121253sf02.tif).
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Figure S2, TIF file, 1.8 MB
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Recombinant fragments F1~P146/232~ and F3~P146/232~ bind heparin. (A) Binding of recombinant protein to biotinylated heparin. Total binding was determined by coating recombinant proteins F1~P146/232~ and F3~P146/232~ (10 µg ml^−1^) to the wells on a 96-well microtiter plate followed by incubation with increasing concentrations of biotinylated heparin (*x* axis). Nonspecific binding was determined by binding with unlabeled heparin in a 50-fold excess to biotinylated heparin. Specific binding was determined by subtracting the nonspecific binding from the total binding. *K~d~* values for recombinant proteins F1~P146/232~ and F3~P146/232~ were determined from the specific binding data. (B) Inhibition of heparin binding by GAGs. Recombinant protein (10 µg ml^−1^) was coated onto the wells of a 96-well microtiter plate and incubated with biotinylated heparin in the presence of an increasing excess of inhibitor (*x* axis). Inhibitors included unlabeled heparin, fucoidan, chondroitin sulfate B, and porcine type II mucin. Download [Figure S3, TIF file, 0.2 MB](/lookup/suppl/doi:10.1128/mBio.00282-11/-/DCSupplemental/mbo002121253sf03.tif).
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Figure S3, TIF file, 0.2 MB
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Recombinant fragments F3~P146/232~ and F3~P146/J~ bind plasminogen. (A and B) Dot blots of recombinant proteins F3~P146/232~ and F3~P146/J~ and controls (bovine serum albumin \[BSA\] and PBS). Each dot contains 1 µg of protein. Blots were stained with amido black (A) or incubated with 10 µg ml^−1^ biotinylated porcine plasminogen and developed with streptavidin-peroxidase and diaminobenzidine (DAB)-hydrogen peroxide (B). (C and D) SPR sensorgrams of F3~P146~ derived from *M. hyopneumoniae* strain J (C) and strain 232 (D) injected over immobilized plasminogen at concentrations of 5 (bottom line), 10, 20, 50, 100, and 200 nM (top line). (E and F) SPR sensorgrams of F3~P146~ derived from *M. hyopneumoniae* strain J (E) and strain 232 (F) without native C-terminal residues (lysine and arginine, respectively) injected over immobilized plasminogen at concentrations of 5 (bottom line), 10, 20, 50, 100 and 200 nM (top line). In all SPR experiments, F3~P146~ homologs were injected at a flow rate of 10 µl min^−1^ for 720 s. The arrows indicate the end of the injection period and initiation of F3~P146~ dissociation from the ligand. Download [Figure S4, TIF file, 0.5 MB](/lookup/suppl/doi:10.1128/mBio.00282-11/-/DCSupplemental/mbo002121253sf04.tif).
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Recombinant fragments F1~P146/232~ to F3~P146/232~ bind porcine epithelial cilia. The results of microtiter plate binding assay showing P146 recombinant fragments binding to porcine cilia are depicted. Recombinant fragment derived from P97 encoding the cilium-binding domain R1 and R2 (F2~P97~) acted as a positive control for cilium binding in this experiment (Deutscher AT, et al., J. Proteome Res. **11**:1924--1936, 2012). The recombinant fragment that has previously been reported to have low cilium binding (F4~Mhp385~) acted as a negative control for cilium binding in this experiment (A. T. Deutscher et al., submitted for publication). Values are means plus least significant differences at *P* \< 0.05 (error bars). Means with any superscript (a to e) in common are not statistically different; means with no superscript in common are different at *P* \< 0.05. Download [Figure S5, TIF file, 0.1 MB](/lookup/suppl/doi:10.1128/mBio.00282-11/-/DCSupplemental/mbo002121253sf05.tif).
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Sequences of primers used in this study
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Table S1, PDF file, 0.1 MB.
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